Cytokine Release Syndrome Following Blinatumomab Therapy

New therapeutic solutions have emerged in the last few decades with the growth and expansion of the field of cancer research. Amongst these new agents, immunotherapy has been prominent, particularly regarding the treatment of hematologic malignancies. One of the most worrisome complications of immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojemolon, Pius E, Kalidindi, Sunaina, Ahlborn, Taylor A, Aihie, Osaigbokan P, Awoyomi, Moyosoluwa I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867529/
https://www.ncbi.nlm.nih.gov/pubmed/35228941
http://dx.doi.org/10.7759/cureus.21583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867529/
https://www.ncbi.nlm.nih.gov/pubmed/35228941
http://dx.doi.org/10.7759/cureus.21583

Ejemplares similares